Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05300815 · ClinicalTrials.gov registry record
Identifying Which Adverse Events Associated With Dry Needling Should be Included For Informed Consent: A Modified e-Delphi Study
A clinical trial of Dry Needling, sponsored by Youngstown State University.
- Completed
- Registry status
- 39
- Enrollment target
- 1
- Study location
NCT05300815: Completed study of Dry Needling, sponsored by Youngstown State University.
NCT05300815 is a study of Dry Needling that has completed, run by Youngstown State University. The registered enrollment target is 39 participants, below the 679-participant average among 4 other Dry Needling trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05300815, a study of Dry Needling, has completed, sponsored by Youngstown State University.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
Dry Needling is an intervention that continues to gain widespread interest as a treatment adjunct for various pathological conditions. With the increased use of dry needling in the clinic, there comes a need for additional research to investigate the adverse events associated with the use of dry needling. Informed Consent is a process that is legally required in many states prior to the performance of a treatment intervention like dry needling. It is important therefore to identify which of these adverse events should be included in an informed consent process.
Primary Outcome
Contains questions about the characteristics of the participants
Conditions Studied
Interventions
- OTHER Delphi Questionaire
Study Locations (1)
Ohio
- Youngstown State University - Youngstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2022-03-02 |
| Est. Completion | 2022-07-31 |
What the finished NCT05300815 record still lists
NCT05300815 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 679-participant average among 4 other Dry Needling trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Dry Needling appearing as the primary indexed condition, and to 1 intervention - of which Delphi Questionaire is the first listed.
NCT05300815 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05300815 about?
NCT05300815 is a clinical study titled "Identifying Which Adverse Events Associated With Dry Needling Should be Included For Informed Consent: A Modified e-Delphi Study". Dry Needling is an intervention that continues to gain widespread interest as a treatment adjunct for various pathological conditions. With the increased use of dry needling in the clinic, there comes a need for additional research to investigate the adverse events associated with the use of dry nee...
What is the current status of trial NCT05300815?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2022-03-02. Estimated completion is 2022-07-31.
What conditions does trial NCT05300815 study?
This clinical trial studies the following conditions: Dry Needling.
What interventions are being tested in trial NCT05300815?
The interventions under investigation include: Delphi Questionaire (OTHER).
Who is sponsoring clinical trial NCT05300815?
This trial is sponsored by Youngstown State University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05300815 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Needling
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dry Needling and Shoulder Muscle Blood Flow, Motions, and Pain Sensitivity in Individuals with Shoulder Pain
ACTIVE NOT RECRUITING · NA
-
How Dry Needling at the Neck Affects Shoulder Movement, Strength, Pain, and Shoulder Circulation
ACTIVE NOT RECRUITING · NA
-
Dry Needling and Shoulder Muscle Blood Flow, Motions, and Pain Sensitivity
COMPLETED · NA
-
Trigger Point Dry Needling Practice in Colorado: Practitioner and Patient
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI